Radiofrequency Ablation Versus Balloon Cryoablation in Elderly Patients With Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- Interventions
- Procedure: ballon cryoablationProcedure: radiofrequency ablation
- Registration Number
- NCT04337567
- Lead Sponsor
- Vivantes Netzwerk für Gesundheit GmbH
- Brief Summary
This study compares the procedural characteristics and effectivity of radiofrequency ablation and cryoablation in patients with atrial fibrillation that are 75 years or older.
- Detailed Description
Radiofrequency and cryoballon ablation have been shown to be comparable to each other in terms of safety and effectivity in patients with atrial fibrillation. However, elderly patients have been underrepresented in the previous studies. The number of older patients with atrial fibrillation is high and the number of who undergo an ablation procedure for atrial fibrillation increases steadily. This prospective randomized trial compares the effectivity (recurrency of atrial arrhythmias) and periprocedural characteristics of the two established ablation methods in patients who are 75 years or older.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- Patients with recurrent symptomatic paroxysmal or persistent atrial fibrillation
- At the day of their inclusion in the study the patients have to have completed the 75th year of life
- Dementia
- Presence of left atrial thrombus
- Left atrial volume> 50 ml/m²
- Renal failure (GFR≤ 30 ml/min)
- Comorbidity with an expected survival of 12 months or less.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Patients over 75 years_ballon cryoablation ballon cryoablation Patients randomized to receive pulmonary vein isolation by means of ballon cryoablation. Patients over 75 years_RF ablation radiofrequency ablation Patients randomized to receive pulmonary vein isolation by means of radiofrequency ablation.
- Primary Outcome Measures
Name Time Method atrial arrhythmia recurrence 1 year Number of Participants with recurrence of any atrial arrhythmia with a duration of 30 sec or longer 12 months after the ablative treatment
- Secondary Outcome Measures
Name Time Method procedural duration periprocedural Duration of the whole procedure \[min\] inclusive preparation (from entrance to the EP lab till exit from the EP lab)
contrast medium dosis periprocedural Amount of contrast medium used
Propofoldosis periprocedural Propofoldosis needed for sedation
vascular complications 1 year Number of Participants in each randomisation arm with deep vein thrombosis, peripheral embolism.
groin complications up to 3 months after dismission from the hospital Number of Participants in each randomisation arm with groin complications (hematoma, av fistel, Aneuryma spurium, infection).
time to wake-up after propofol withdrawal periprocedural Time from withdrawal of propofole till patient awake and fully oriented (time, place, person)
Neurological complications 1 year Number of Participants in each randomisation arm with transient ischemic attack, cerebral insult, cerebral haemorrhage
duration of hospital staying [days] 1 year duration of hospital staying: from admission till discharge in days
Trial Locations
- Locations (1)
Vivantes Klinikum Neukölln
🇩🇪Berlin, Germany